$70 million CytoSen deal
Central Florida, which has invested heavily in life sciences over the past decade and a half, reached a milestone in June: Kiadis Pharma, an Amsterdam-based cell-therapy company, bought Winter Springs-based CytoSen Therapeutics in a deal that could eventually be valued at $70 million — the biggest biotech sale in the region’s history, eclipsing the region’s previous record, set in 2015 when VaxDesign sold for $60 million.
This story also features expert opinions, business briefs and people in the news: Robert Igarashi; Alicja Copik;
Want to read the whole article?
Select from the following options:
* offer valid for new subscribers only